Sorafenib treatment for recurrent hepatocellular carcinoma after liver transplantation

Transplantation Proceedings

Volumn 44, Issue 9, 2012, Pages 2754-2756

  Sotiropoulos, G C ^a   Nowak, K W ^a   Fouzas, I ^a   Vernadakis, S ^a   Kykalos, S ^a   Klein, C G ^a   Paul, A ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; SORAFENIB;

ADULT; ALCOHOL LIVER DISEASE; AUTOIMMUNE HEPATITIS; CAUSE OF DEATH; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; FOLLOW UP; FOURNIER GANGRENE; HEMOCHROMATOSIS; HEMORRHAGIC SHOCK; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LUNG TUMOR; MALE; MEDIASTINUM LYMPH NODE; PELVIS TUMOR; PLEURA CAVITY; PNEUMONIA; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT DURATION; TUMOR VOLUME; WILSON DISEASE;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NIACINAMIDE; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84869012575     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.09.022     Document Type: Conference Paper

References (19)

1. S. Jelic, G.C. Sotiropoulos ESMO Guidelines Working Group Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 suppl 5 2010 v59 v64
2. A. Valdivieso, J. Bustamante, M. Gastaca Management of hepatocellular carcinoma recurrence after liver transplantation Transplant Proc 42 2010 660
3. V.R. Cicinnati, G.C. Sotiropoulos, S. Beckebaum Established and emerging therapies for hepatocellular carcinoma Minerva Med 101 2010 405
4. A.A. Schnitzbauer, C. Zuelke, C. Graeb A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma BMC Cancer 10 2010 190
5. J.M. Llovet, S. Ricci, V. Mazzaferro SHARP Investigators Study Group Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378
6. S. Bhoori, S. Toffanin, C. Sposito Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle J Hepatol 52 2010 771
7. P. Newell, S. Toffanin, A. Villanueva Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo J Hepatol 51 2009 725
8. Z. Wang, J. Zhou, J. Fan Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma Clin Cancer Res 14 2008 5124
9. J.M. Llovet, A. Burroughs, J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907
10. G.C. Sotiropoulos, H. Lang, S. Nadalin Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors J Am Coll Surg 205 2007 661
11. G.C. Sotiropoulos, N. Drühe, G. Sgourakis Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci 54 2009 2264
12. M. Peck-Radosavljevic, T.F. Greten, J. Lammer Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma Eur J Gastroenterol Hepatol 22 2010 391
13. A. Weinmann, I.M. Niederle, S. Koch Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation Dig Liver Dis 44 2012 432
14. C. Gomez-Martin, J. Bustamante, J.F. Castroagudin Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation Liver Transpl 18 2012 45
15. S. Bhoori, S. Toffanin, C. Sposito Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle J Hepatol 52 2010 771
16. J.O. Lee, D.Y. Kim, J.H. Lim Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation J Gastroenterol Hepatol 24 2009 800
17. Y. Wang, K.V. Speeg, W.K. Washburn Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: a case report World J Gastroenterol 16 2010 5518
18. D.H. Yoon, B.Y. Ryoo, M.H. Ryu Sorafenib for recurrent hepatocellular carcinoma after liver transplantation Jpn J Clin Oncol 40 2010 768
19. O. Waidmann, W.P. Hofmann, S. Zeuzem mTOR inhibitors and sorafenib recurrent heptocellular carcinoma after orthotopic liver transplantation J Hepatol 54 2011 396